Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says By Reuters Stocks March 29, 2024 By Patrick Wingrove (Reuters) – Gerresheimer CEO Dietmar Siemssen said he expects about 4% of the company’s revenue growth per…